spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  bipolar 

 HSMN NewsFeed - 30 Aug 2023
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 7 Aug 2023
NRx Pharmaceuticals Announces the Licensure of a US Patent to Support Use of NRX-101(TM) for Chronic Pain
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Feb 2023
Candela Introduces the New FDA-Cleared Profound Matrix(TM) System
Devices Dermatology FDA Product Launch
 HSMN NewsFeed - 5 Dec 2022
NRx Pharmaceuticals Announces the Appointment of Carrie M. Carretta, PhD, APN-BC, AHN-BC, PMHNP, Senior Vice President of Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 17 Oct 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Devices Cardiology FDA
 HSMN NewsFeed - 28 Sep 2022
Olympus Launches THUNDERBEAT Energy Device for Open Surgery
Devices Surgery Product Launch
 HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 18 Mar 2022
NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Chief Financial Officer and Treasurer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jan 2022
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 Dec 2021
Healis Therapeutics announces mission to deliver new class of neuromuscular treatments in psychiatry
Biopharmaceuticals
 HSMN NewsFeed - 17 Aug 2021
Smith & Nephew expands its leading WEREWOLF(TM) Technology into total joint arthroplasty with launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand
Devices Orthopaedic Surgery Product Launch
 HSMN NewsFeed - 2 Aug 2021
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jul 2021
Corium Launches Innovative ADHD Treatment AZSTARYS(TM) (serdexmethylphenidate and dexmethylphenidate) in the U.S. for Patients Age 6 Years and Older
Biopharmaceutical Neurology Product Launch
 HSMN NewsFeed - 9 Jul 2021
Single Pass Closes Seed Funding Round
Devices Surgery Venture Capital
 HSMN NewsFeed - 21 Jun 2021
Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer
Devices Surgery Product Launch
 HSMN NewsFeed - 11 Mar 2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Sep 2020
Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners
Biopharmaceuticals
 HSMN NewsFeed - 6 Aug 2020
FDA grants inhaled use IND for RLF-100 (aviptadil) to treat patients with moderate and severe COVID-19 aiming to prevent progression to respiratory failure
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 May 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 23 Oct 2019
NeuroRx Secures HK$ 750 Million Capital Commitment From The Gem Group for Development of NRX-101
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Aug 2019
Corinth MedTech Appoints Steven Duddy as New President and CEO
Devices Urology Personnel
 HSMN NewsFeed - 15 Jul 2019
Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 May 2019
Smith & Nephew launches new FLOW 90(TM) Wand at ISAKOS joining its innovative collection of COBLATION(TM) technology and shoulder repair portfolios
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 29 Aug 2018
Impel NeuroPharma Annouces First Subject Dosed In Phase 1 Trial Evaluating INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 22 Jun 2018
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 30 May 2018
Olympus Launches the DualKnife J, an ESD Electrosurgical Knife That Shortens Procedure Time
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 28 May 2018
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 27 Dec 2017
NeuroRx Signs Agreement With U.S. Dept. of Veterans Affairs and Baylor College of Medicine for Clinical Trial of First Drug Regimen Targeting Severe Bipolar Depression in Patients With Acute Suicidal Ideation & Behavior (ASIB)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Nov 2017
Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda(R) (Lurasidone Hydrochloride) in Europe
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 13 Nov 2017
Allergan Receives FDA Approval For Use of VRAYLAR(TM) (cariprazine) in the Maintenance Treatment of Schizophrenia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Oct 2017
Neurocrine Announces FDA Approval of 80 mg INGREZZA(R) (valbenazine) Capsules for the Treatment of Adults with Tardive Dyskinesia (TD)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Sep 2017
NeuroRx Awarded FDA Fast Track Designation for First Drug Regimen Targeting Suicide in Bipolar Depression
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 May 2017
Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 21 Apr 2017
Neurocrine Announces INGREZZA(TM) Long-Term Safety and Efficacy Data to be Presented at the 2017 American Academy of Neurology Annual Meeting
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Mar 2017
Revolutionary UroLift(R) System Launches in Ireland
Devices Urology Product Launch
 HSMN NewsFeed - 7 Mar 2017
Ethicon Launches ENSEAL(R) X1 Large Jaw Tissue Sealer, Establishing Next Generation Of Advanced Bipolar Devices
Devices Surgery Product Launch
 HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution
 HSMN NewsFeed - 7 Nov 2016
St. Jude Medical Gains CE Mark Approval for MRI Labeling of its Quadra Allure MP Cardiac Resynchronization Therapy Pacemaker
Devices Cardiology Radiology Regulatory
 HSMN NewsFeed - 4 Nov 2016
The GeneSight(R) Precision Medicine Test Drives Significant Medication Cost Savings in Patients with Generalized Anxiety Disorder
Diagnostics Personalized Medicine
 HSMN NewsFeed - 2 Nov 2016
HOYA Group PENTAX Medical Launch HemoStat WideCup(TM), The New Bipolar Hot Hemostasis Forceps Contributing to Early Treatment of Gastric Cancer
Devices Oncology Product Launch
 HSMN NewsFeed - 16 Aug 2016
Bovie Medical Receives FDA 510(k) Clearance for Its PlazXact(TM) Ablator
Devices Orthopaedic Surgery FDA
 HSMN NewsFeed - 5 Aug 2016
Allergan and Richter Provide Update on Cariprazine Program
Biopharmaceuticals
 HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 16 May 2016
Neos Therapeutics Announces U.S. Launch of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients Six Years and Older
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 16 Mar 2016
Allergan Announces U.S. Availability of VRAYLAR(TM) (cariprazine) for Treatment of Bipolar Mania and Schizophrenia in Adults
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 17 Feb 2016
Impax Receives FDA Approval for Generic Version of Adderall XR(R) (mixed salts of a single-entity amphetamine product) Capsules, CII
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 3 Aug 2015
Intra-Cellular Therapies Expands Leadership Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Apr 2015
Ethicon’s HARMONIC FOCUS(R)+ Shears Now Proven to Produce Vessel Seal Strength Equivalent to Advanced Bipolar Devices
Devices Surgery
 HSMN NewsFeed - 13 Mar 2015
Actavis Receives FDA Approval of SAPHRIS(R) for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Dec 2014
Tal Medical Appoints Atul Pande, M.D., Former SVP and Head of Neurosciences at GSK, as Chief Medical Officer, EVP and SAB member
Devices Neurology Personnel
 HSMN NewsFeed - 17 Nov 2014
First U.S. Procedures Completed With The Symphion(TM) Hysteroscopic Tissue Removal System
Devices Product Launch
 HSMN NewsFeed - 29 Sep 2014
Intuitive Surgical Receives FDA Clearance for First Single-Site(R) Wristed Needle Driver for da Vinci(R) Si(R) Surgical System
Devices Surgery FDA
 HSMN NewsFeed - 31 Jul 2014
Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 9 Apr 2014
Brainsway's Deep TMS System Will be Exclusively Marketed by Medison Pharma in Israel
Devices Neurology Distribution
 HSMN NewsFeed - 24 Mar 2014
St. Jude Medical Announces FDA Approvals of New Pacemakers
Devices Cardiology FDA
 HSMN NewsFeed - 10 Mar 2014
Intra-Cellular Therapies Announces the Appointment of Juan Sanchez, M.D., as Vice President of Corporate Communications and Investor Relations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 18 Feb 2014
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Jan 2014
Covidien Receives U.S. Food and Drug Administration Clearance for LigaSure(TM) Maryland Jaw
Devices Surgery FDA
 HSMN NewsFeed - 2 Jan 2014
AtriCure Completes Acquisition of Estech
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 11 Dec 2013
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
Devices Surgery FDA
 HSMN NewsFeed - 2 Dec 2013
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 21 Nov 2013
Megadyne(R) Announces Collaboration Agreement with ETHICON
Devices Surgery Distribution
 HSMN NewsFeed - 21 Nov 2013
Ethicon Announces Collaboration Agreement with MEGADYNE(R)
Devices Surgery Distribution
 HSMN NewsFeed - 21 Nov 2013
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Nov 2013
Ethicon Energy Launches ENSEAL(R) G2 Articulating at AAGL Global Congress on Minimally Invasive Gynecology
Devices Surgery Product Launch
 HSMN NewsFeed - 5 Nov 2013
First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Oct 2013
Ethicon Receives 510(k) Clearance of Ear, Nose and Throat (ENT) Indication for ENSEAL(R) Tissue Sealers
Devices FDA
 HSMN NewsFeed - 28 Oct 2013
Ethicon Receives 510(k) Clearance for New HARMONIC ACE(R)+ 7 Shears with Advanced Hemostasis
Devices Surgery FDA
 HSMN NewsFeed - 30 Jul 2013
Alexza Pharmaceuticals Announces European Launch of ADASUVE(R) (Staccato(R) Loxapine)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 18 Jun 2013
Promising Mid-Term Results From Thoracoscopic Ablation of Persistent Atrial Fibrillation Presented at Meeting of International Society for Minimally Invasive Cardiothoracic Surgery
Devices Cardiology
 HSMN NewsFeed - 17 May 2013
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
Devices Interventional Cardiology
 HSMN NewsFeed - 8 May 2013
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Apr 2013
St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
Devices Cardiology Regulatory Product Launch
 HSMN NewsFeed - 20 Mar 2013
Ethicon Receives 510(K) Clearance for ENSEAL(R) G2 Cordless
Devices Surgery FDA
 HSMN NewsFeed - 21 Feb 2013
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Feb 2013
Ethicon Receives 510(k) Clearance for ENSEAL(R) G2 Articulating Tissue Sealer
Devices Surgery FDA
 HSMN NewsFeed - 30 Jan 2013
Encision Launches Three New Products, Including the EM3 AEM(R) Monitor
Devices Monitoring Surgery Product Launch
 HSMN NewsFeed - 22 Jan 2013
Physicians Report Successful Clinical Use of the DFINE STAR(TM) Tumor Ablation System in Malignant Lesions of the Spine
Devices Orthopaedic Neurosurgery Oncology
 HSMN NewsFeed - 14 Dec 2012
The CHMP Delivers a Positive Opinion Recommending Grant of Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Oct 2012
Richard Wolf Introduces the Smallest Bipolar Resectoscope on the Market
Devices Surgery
 HSMN NewsFeed - 17 Oct 2012
DelRey ENT Associates Enhances the Care and Comfort of Tonsillectomy Patients with Thermal Fusion Technology
Devices
 HSMN NewsFeed - 15 Oct 2012
Corcept Therapeutics Appoints Daniel M. Bradbury to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Aug 2012
Wockhardt receives tentative US FDA approval for generic version of anti-psychotic drug Geodon(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Aug 2012
First Cardiac Surgery with Domain Surgical FMwand Completed at Beaumont Hospital
Devices Surgery
 HSMN NewsFeed - 10 Aug 2012
Neuren Appoints Joseph Horrigan, M.D., as VP of Clinical Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Aug 2012
Ethicon Endo-Surgery Receives 510(k) Clearance for New HARMONIC ACE(R)+ Shears with Adaptive Tissue Technology
Devices Surgery FDA
 HSMN NewsFeed - 25 Jul 2012
NuPathe Appoints Armando Anido as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 12 Jul 2012
Covidien Announces New Bipolar Resection Software Application for ForceTriad(TM) Energy Platform
Devices Urology Surgery
 HSMN NewsFeed - 1 May 2012
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 8 Mar 2012
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
Devices Oncology
 HSMN NewsFeed - 29 Feb 2012
Conceptus(R) Receives FDA Approval for Compatible Use of Hologic's NovaSure(R) with Essure(R) Inserts in Place
Devices
 HSMN NewsFeed - 28 Feb 2012
Forest Laboratories, Inc. and Gedeon Richter Plc. Announce Results from Two Positive Phase III Trials with the Investigational Antipsychotic Cariprazine for the Treatment of Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 8 Feb 2012
Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 23 Jan 2012
Medtronic Announces 510(k) Clearance for the Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 2 Dec 2011
Missouri Baptist Medical Center Physicians Are First in Missouri to Implant New Heart Failure Device
Devices Cardiology
 HSMN NewsFeed - 21 Nov 2011
Covidien Announces Definitive Agreement to Acquire BÂRRX Medical, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 17 Oct 2011
Medtronic Announces 510(k) Clearance for the Aquamantys(R)3 System with Combined Hemostatic Sealing and Cutting Functionality
Devices FDA
 HSMN NewsFeed - 12 Oct 2011
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
Regenerative Medicine Neurology
 HSMN NewsFeed - 3 Aug 2011
Symmetry Medical to Acquire Olsen Medical
Devices Orthopaedic Surgery Mergers & Acquisitions
 HSMN NewsFeed - 20 Jul 2011
Ethicon Endo-Surgery Launches ENSEAL(R) G2 Super Jaw First Bi-Polar Advanced Energy Technology Designed to Improve Surgeon Confidence in Tissue Affect
Devices Surgery
 HSMN NewsFeed - 16 Jun 2011
Ethicon Endo-Surgery Introduces Innovative New Generator to Help Simplify Use of Advanced Energy Technology in the OR
Devices Surgery
 HSMN NewsFeed - 15 Jun 2011
Ethicon Endo-Surgery Launches ENSEAL(R) G2 Super Jaw
Devices Surgery
 HSMN NewsFeed - 14 Jun 2011
Neuralstem Updates ALS Clinical Trial Progress
Regenerative Medicine Neurology
 HSMN NewsFeed - 9 May 2011
Alkermes to Merge with Elan Drug Technologies to Create Alkermes plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 May 2011
Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation
Devices Cardiology
 HSMN NewsFeed - 2 May 2011
Sorin Group Launches the VascuClear(TM) Endoscopic Vessel Harvesting System
Devices Interventional
 HSMN NewsFeed - 31 Mar 2011
Microline Surgical Launches MiSeal(TM) Reposable Thermal Ligating System at SAGES 2011 Annual Meeting
Devices Surgery
 HSMN NewsFeed - 18 Mar 2011
Utah Medical Products, Inc. Acquires Femcare Group Limited
Devices Mergers & Acquisitions
 HSMN NewsFeed - 9 Mar 2011
Salient Surgical Technologies Settles Bovie Medical Patent Infringement Lawsuit
Devices Surgery Litigation
 HSMN NewsFeed - 4 Mar 2011
Bovie Medical Corporation Announces Settlement of Litigation with Salient Surgical and Medtronic
Devices Surgery Litigation
 HSMN NewsFeed - 24 Jan 2011
Bausch & Lomb Storz(R) Ophthalmics Introduces Additions to Its Single-Use Vitreoretinal Instruments Line
Devices Ophthalmology
 HSMN NewsFeed - 24 Jan 2011
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Dec 2010
Synergetics USA Introduces Next Generation Electrosurgical Generator
Devices Surgery Neurosurgery Distribution
 HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Oct 2010
Estech Launches the COBRA Revolution(TM) Bipolar Clamp for Surgical Ablation
Devices Cardiology Surgery
 HSMN NewsFeed - 28 Sep 2010
AstraZeneca UK Receives Positive Decision For Seroquel XL(R)[Black Triangle Drug] (Quetiapine Prolonged Release) as an Add-On Treatment of Major Depressive Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Aug 2010
Darl Moreland Joins Alexza Pharmaceuticals as Vice President, Quality
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2010
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
Biopharmaceuticals
 HSMN NewsFeed - 22 Jul 2010
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2010
BARRX Medical, Inc. Completes $15 Million Growth Financing
Devices Gastroenterology Venture Capital
 HSMN NewsFeed - 14 Jun 2010
AtriCure's AtriClip System Receives FDA 510(k) Clearance
Devices Cardiology FDA
 HSMN NewsFeed - 26 May 2010
Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2010
Epizyme Appoints Mikel Moyer, Ph.D., Vice President of Molecular Discovery
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2010
Solta Medical and Alma Lasers Resolve Patent Lawsuits
Devices Litigation
 HSMN NewsFeed - 14 Apr 2010
Salient Surgical Brings the Benefits of TRANSCOLLATION(TM) Technology to the Orthopedic Trauma Market
Devices Surgery Orthopaedic
 HSMN NewsFeed - 29 Mar 2010
Megadyne Introduces the ACE Blade, the Safe and Effective Cutting Device
Devices Surgery
 HSMN NewsFeed - 19 Mar 2010
Bovie Medical Corporation Announces Clearance to Market Its BOSS Soft Tissue Coagulation Device
Devices Surgery FDA
 HSMN NewsFeed - 12 Mar 2010
Bovie Medical Corporation Announces Clearance to Market Its ICON VS Electrosurgical Generator
Devices Surgery FDA
 HSMN NewsFeed - 11 Mar 2010
Illumina and Glenn Close Announce the First Full Coverage DNA Sequencing of a Named Female
Diagnostics
 HSMN NewsFeed - 3 Feb 2010
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals
 HSMN NewsFeed - 5 Jan 2010
Corcept Therapeutics Announces Four Anticipated Milestones for 2010
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Dec 2009
FDA Approves Lilly's Zyprexa for Two Adolescent Indications
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Dec 2009
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Nov 2009
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Nov 2009
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2009
Synergetics USA, Inc. Announces Addendum to Marketing Partner Agreement with Codman & Shurtleff, Inc. for Disposable Bipolar Forceps
Devices Neurosurgery Distribution
 HSMN NewsFeed - 4 Nov 2009
AtriCure Announces Tentative Settlement with the Department of Justice
Devices Cardiology Litigation
 HSMN NewsFeed - 6 Oct 2009
AtriCure Announces European Approval for its AtriClip System
Devices Cardiology Regulatory
 HSMN NewsFeed - 5 Oct 2009
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Sep 2009
Medtronic Launches New and Innovative Intraoperative Nerve Integrity Monitors for Surgeons
Devices Monitoring Surgery
 HSMN NewsFeed - 14 Sep 2009
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
Biopharmaceuticals
 HSMN NewsFeed - 24 Jul 2009
SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 22 Jul 2009
Bovie Medical Corporation Announces 510(k) Submissions to the FDA for Its Seal-N-Cut Vessel Sealing Instruments
Devices Surgery FDA
 HSMN NewsFeed - 1 Jul 2009
Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
Biopharmaceuticals
 HSMN NewsFeed - 19 Jun 2009
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
Devices Surgery
 HSMN NewsFeed - 3 Jun 2009
Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox
Devices Surgery
 HSMN NewsFeed - 2 Jun 2009
Schering-Plough Announces European Filing of SYCREST(R) (asenapine) for the Treatment of Schizophrenia and Bipolar I Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Jun 2009
Cephalon Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder and Narcolepsy
Biopharmaceuticals
 HSMN NewsFeed - 18 May 2009
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 May 2009
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 May 2009
Eurand Announces FDA Approval of EUR-1048 (Lamictal(R) ODT(TM)), Co-Developed With GlaxoSmithKline
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Apr 2009
Microline PENTAX Acquires Starion Instruments
Devices Acquisitions
 HSMN NewsFeed - 7 Apr 2009
Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2009
Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
Biopharmaceuticals
 HSMN NewsFeed - 27 Mar 2009
AtriCure's Cryoablation System, Cryo1, Receives FDA 510(k) Clearance
Devices Cardiology FDA
 HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Mar 2009
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 17 Mar 2009
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
Biopharmaceuticals
 HSMN NewsFeed - 16 Mar 2009
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Mar 2009
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Mar 2009
Merck and Schering-Plough to Merge
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Feb 2009
Salient Surgical Technologies Launches New Advanced Energy Device Designed to Improve Patient Outcomes in Spine Surgery
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 24 Feb 2009
Hydromer, Inc. Announces Sale of Product Lines to Merit Medical Systems, Inc.
Devices Acquisitions
 HSMN NewsFeed - 24 Feb 2009
CHMP delays European Commission decision process to approve ZEVTERA(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Feb 2009
AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
Biopharmaceuticals
 HSMN NewsFeed - 20 Feb 2009
Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2009
Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2009
FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Feb 2009
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jan 2009
Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 28 Jan 2009
Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 27 Jan 2009
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
Biopharmaceuticals
 HSMN NewsFeed - 22 Jan 2009
Cardo Medical Announces the Initial Release of Its Press-Fit Total Hip System
Devices Orthopaedic
 HSMN NewsFeed - 15 Jan 2009
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Biopharmaceuticals
 HSMN NewsFeed - 14 Jan 2009
U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2009
Synergetics USA, Inc. Announces Three Month Extension of Current Agreements with Codman & Shurtleff, Inc. as Longer Term Agreement Negotiations Continue
Devices Neurosurgery Licensing
 HSMN NewsFeed - 10 Oct 2008
FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Oct 2008
Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2008
Eli Lilly and Company Resolves Investigation Involving Numerous States
Biopharmaceuticals
 HSMN NewsFeed - 26 Sep 2008
CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Sep 2008
New Studies Highlight Benefits of Coblation(R)-Assisted Procedures in Airway Fire Prevention and Endoscopic Sinus Surgery
Devices Surgery
 HSMN NewsFeed - 16 Sep 2008
Mylan Receives FDA Approval for Generic Version of Anti-Psychotic Risperdal(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Sep 2008
CSMG Technologies Subsidiary Live Tissue Connect Awarded European Union CE Mark Certificate; Follows Recent U.S. FDA Clearance
Devices Regulatory
 HSMN NewsFeed - 25 Aug 2008
Noven Provides Update on Daytrana(R) Methylphenidate Transdermal System
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2008
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jul 2008
Noven Announces Final FDA Approval of Stavzor(TM) for the Treatment of Bipolar Disorder, Seizures and Migraine Headaches
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jul 2008
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 9 Jul 2008
Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2008
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2008
Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
Devices Cardiology
 HSMN NewsFeed - 11 Jun 2008
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2008
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 29 May 2008
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2008
Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 May 2008
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2008
FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2008
Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
Biopharmaceuticals
 HSMN NewsFeed - 23 Apr 2008
FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Apr 2008
Covidien Unveils the Next Generation in Advanced Surgery
Devices Surgery
 HSMN NewsFeed - 8 Apr 2008
Bristol-Myers Squibb and Otsuka Receive European Marketing Authorisation for ABILIFY(R) in the Treatment and Prevention of Moderate to Severe Manic Episodes in Bipolar I Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Mar 2008
AtriCure's Coolrail(TM) Linear Ablation Pen Receives FDA 510(k) Clearance
Devices Cardiology FDA
 HSMN NewsFeed - 12 Mar 2008
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
Biopharmaceuticals
 HSMN NewsFeed - 29 Feb 2008
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Feb 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
Biopharmaceuticals
 HSMN NewsFeed - 28 Feb 2008
FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Feb 2008
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2008
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Biopharmaceuticals
 HSMN NewsFeed - 11 Feb 2008
AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 7 Feb 2008
AtriCure Appoints Mark A. Collar to its Board of Directors
Devices Personnel
 HSMN NewsFeed - 6 Feb 2008
FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Jan 2008
Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
Devices Surgery
 HSMN NewsFeed - 18 Jan 2008
In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
Biopharmaceuticals
 HSMN NewsFeed - 18 Jan 2008
Pfizer Statement on CHANTIX (varenicline) Labeling Update in the United States
Biopharmaceuticals
 HSMN NewsFeed - 16 Jan 2008
CSMG Technologies Announces Frank D'Amelio to Become President and Board Member of its Subsidiary Live Tissue Connect, Inc.
Devices Personnel
 HSMN NewsFeed - 14 Jan 2008
Surgeons and Electrophysiologist Publish Positive Data Using AtriCure Minimally Invasive Products
Devices Cardiology
 HSMN NewsFeed - 3 Jan 2008
FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Dec 2007
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Dec 2007
INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 26 Nov 2007
Synergetics USA, Inc. Adds New Electrosurgical Generator to Its Neurosurgical Product Line
Devices Neurosurgery
 HSMN NewsFeed - 20 Nov 2007
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2007
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Nov 2007
ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Nov 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 9 Nov 2007
Synergetics Announces a New Executive Vice President of Sales and Marketing
Devices Personnel
 HSMN NewsFeed - 6 Nov 2007
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Nov 2007
ArthroCare Launches New, Intelligent Controller and Upgraded Coblation Wands to Enable Advanced Arthroscopic Surgery
Devices Surgery
 HSMN NewsFeed - 30 Oct 2007
Synergetics USA, Inc. Adds "Energy BurstTM" to Malis(R) AdvantageTM Electrosurgical Generator
Devices Surgery
 HSMN NewsFeed - 29 Oct 2007
Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Oct 2007
New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
Biopharmaceuticals
 HSMN NewsFeed - 25 Oct 2007
Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2007
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Oct 2007
New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Oct 2007
Immersion Medical Introduces OB/GYN Module for LaparoscopyVR(TM) Surgical Simulator
Devices Surgery
 HSMN NewsFeed - 5 Oct 2007
Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
Biopharmaceuticals
 HSMN NewsFeed - 20 Sep 2007
Robert S. Fishman, MD, FCCP Joins Alexza as Vice President, Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2007
Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Sep 2007
AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
Devices Cardiology
 HSMN NewsFeed - 7 Sep 2007
Statement of Eli Lilly and Company on Dr. David Egilman Settlement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 4 Sep 2007
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 Sep 2007
Shire Voluntarily Withdraws a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 27 Aug 2007
Synergetics USA, Inc. Announces an Extension to the Stryker Contract
Devices Distribution
 HSMN NewsFeed - 22 Aug 2007
FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Aug 2007
Noven Completes Acquisition of JDS Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Aug 2007
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
Biopharmaceuticals
 HSMN NewsFeed - 1 Aug 2007
American Academy of Dermatology Says New Technologies Tighten Skin From Head to Toe Without Surgery
Devices Dermatology
 HSMN NewsFeed - 27 Jul 2007
Shire's New ADHD Medication, VYVANSE(TM) (lisdexamfetamine dimesylate) Now Available in U.S. Pharmacies Nationwide
Biopharmaceuticals
 HSMN NewsFeed - 17 Jul 2007
ABILIFY(R) (aripiprazole) Supplemental New Drug Application Receives Priority Review by U.S. Food And Drug Administration for Adjunctive Treatment in Adults With Major Depressive Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Jul 2007
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Jul 2007
AtriCure's Isolator(R) Bipolar Ablation Clamp System Receives FDA 510(k) Clearance for Cardiac Use
Devices Cardiology FDA
 HSMN NewsFeed - 29 Jun 2007
Shire Announces Filing of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults
Biopharmaceuticals
 HSMN NewsFeed - 28 Jun 2007
INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 21 Jun 2007
FDA Issues Approvable Letter for RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jun 2007
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Jun 2007
Noven & Shire to Develop New Transdermal Patch For ADHD
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 19 Jun 2007
IMPAX Announces Lawsuit Related to Generic Version of Depakote ER
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Jun 2007
Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jun 2007
Studies Presented at International Society of Minimally Invasive Cardiac Surgery on the Superior Clinical Outcomes Using the ESTECH COBRA(R) Product Line for Cardiac Ablation
Devices Cardiology
 HSMN NewsFeed - 5 Jun 2007
Vanda Pharmaceuticals Announces Board Changes
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 Jun 2007
Barr Announces Tentative Approval for a Generic Version of Risperdal(R) Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 May 2007
FDA Issues Approvable Letter for SPD465 (Triple-Bead Mixed Amphetamine Salts) for the Treatment of ADHD in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 May 2007
ESTECH COBRA(R) Devices and Patented ''Box Lesion'' Acknowledged as Key Elements in Successful Cardiac Ablation at Recent American Association for Thoracic Surgery 87th Annual Meeting
Devices Cardiology
 HSMN NewsFeed - 15 May 2007
Novel Therapy for Treating Malignant Tumors in Spine Presented at World Conference on Interventional Oncology
Devices Orthopaedic Neurosurgery Oncology
 HSMN NewsFeed - 15 May 2007
ArthroCare Receives FDA Clearance to Treat Malignant Lesions in the Spine
Devices FDA Orthopaedic Neurosurgery
 HSMN NewsFeed - 10 May 2007
Synergetics USA, Inc. Announces the Launch of the Largest Line of 23 Gauge Retinal Surgical Instruments
Devices Surgery Ophthalmology
 HSMN NewsFeed - 4 May 2007
Bovie Medical Corporation Completes Acquisition of Remaining 50% Interest in J-Plasma
Devices Mergers & Acquisitions
 HSMN NewsFeed - 3 May 2007
Synergetics USA Announces First One Step(TM) Chandelier for Retina Surgery
Devices Ophthalmology Surgery
 HSMN NewsFeed - 3 May 2007
St. Jude Medical Announces U.S. And European Approvals of Zephyr Pacemaker Family of Devices
Devices Cardiology FDA Regulatory
 HSMN NewsFeed - 3 May 2007
VYVANSE(TM) (lisdexamfetamine dimesylate) Receives Final DEA Schedule Classification, Clearing Way for Launch of First Prodrug Stimulant for Treatment of ADHD
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2007
New Data Shows Once a Day Lamictal(R) XR(TM) Is Effective in Treating Patients With Partial Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Apr 2007
FDA Approves INVEGA (TM) for Long-Term Maintenance Treatment of Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Apr 2007
INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Apr 2007
Diffusion Pharmaceuticals Announces Formation of Scientific Advisory Board Chaired by Company Co-founder, John L. Gainer, Ph.D.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2007
Wright Medical Group, Inc. Expands Hip Product Portfolio With Key Product Launches
Devices Orthopaedic
 HSMN NewsFeed - 13 Apr 2007
FDA Approves New Dose of RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Apr 2007
Synergetics Announces Settlement of Patent Litigation
Devices Surgery Litigation Licensing
 HSMN NewsFeed - 30 Mar 2007
Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Mar 2007
Study Suggests INVEGA(TM) Helps Patients With Schizophrenia Maintain Symptom Control
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2007
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 16 Mar 2007
Diffusion Pharmaceuticals Initiates Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2007
Bovie Medical Corporation Announces Completion of Development of Monopolar and Bipolar Modular Forceps; Expected to Significantly Impact Future Growth
Devices Surgery
 HSMN NewsFeed - 12 Mar 2007
Schering-Plough to Acquire Organon BioSciences
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2007
FDA Grants Pediatric Exclusivity for RISPERDAL(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Feb 2007
Eli Lilly and Company Statement: Judge Grants Lilly's Request for a Permanent Injunction Involving Misleading Selection of Illegally Leaked Lilly Documents
Biopharmaceuticals Litigation
 HSMN NewsFeed - 6 Feb 2007
AtriCure Receives FDA 510(k) Clearance for Isolator(TM) Synergy(TM) Bipolar Ablation System and Performs First Case
Devices FDA
 HSMN NewsFeed - 5 Feb 2007
Centers for Medicare and Medicaid Services (CMS) Declines Cyberonics' Formal Request to Expand Coverage of VNS Therapy
Devices Reimbursement
 HSMN NewsFeed - 30 Jan 2007
Cytyc Announces New UK NICE Clinical Guideline Recommends Endometrial Ablation Instead of Hysterectomy For Most Women with Heavy Menstrual Bleeding
Devices
 HSMN NewsFeed - 11 Jan 2007
Synergetics USA, Inc. Taps the Spinal Markets
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 11 Jan 2007
Wyeth and Solvay Enter Into an Additional Neuroscience Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 9 Jan 2007
AtriCure Hires Julie Piton as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 4 Jan 2007
Eli Lilly and Company Statement Regarding Today's New York Times Article - January 4, 2007
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2007
Lilly and Plaintiffs' Attorneys Enter Into Agreements to Settle Zyprexa(R) Product Liability Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Jan 2007
D-Pharm Announces Positive Phase IIb Trial Results for DP-b99 in Acute Stroke Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Dec 2006
INVEGA(TM) Approved By FDA as New Treatment for Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2006
Statement from Eli Lilly and Company: Response to The New York Times Article from December 18, 2006
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2006
ABILIFY(R) (Aripiprazole) Injection for Intramuscular Use for Adults With Agitation Associated With Schizophrenia or Bipolar Mania Now Available
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2006
Memory Pharmaceuticals Announces Release of Clinical Hold on MEM 3454
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Dec 2006
ABILIFY(R) (aripiprazole) Demonstrated Efficacy as Long-Term Maintenance Therapy in Adults With Bipolar I Disorder Following Treatment for a Recent Manic Or Mixed Episode
Biopharmaceuticals
 HSMN NewsFeed - 7 Dec 2006
Vanda Pharmaceuticals Confirms Iloperidone Efficacy With Positive Phase III Clinical Trial Results in Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2006
Cerimon Pharmaceuticals Names Ayse Kocak Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2006
Lilly Responds to the Cost-Effectiveness Analysis of the CATIE Schizophrenia Trial
Biopharmaceuticals
 HSMN NewsFeed - 28 Nov 2006
Valleylab Announces New, Integrated ForceTriad(TM) Energy Platform for Electrosurgery
Devices Surgery
 HSMN NewsFeed - 28 Nov 2006
Organon and Pfizer Discontinue Their Collaboration on Asenapine
Biopharmaceuticals
 HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
Biopharmaceuticals
 HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of a Meta-Analysis Comparing Stimulant Medications to Non-Stimulant Medications in Treating ADHD in Patients Aged 8 to 15
Biopharmaceuticals
 HSMN NewsFeed - 15 Nov 2006
Vanda Pharmaceuticals' VEC-162 Demonstrates Positive Results in a Phase III Transient Insomnia Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 14 Nov 2006
Diffusion Pharmaceuticals Strengthens Management Team With Appointment of Matthew W. Hantzmon as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2006
Corcept Therapeutics Completes Enrollment in Third Phase 3 Study for Treating Psychotic Major Depression
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2006
Bovie Medical Corporation Announces Formation of Canadian Medical Technology and Manufacturing Division Through Asset Acquisition
Devices Mergers & Acquisitions
 HSMN NewsFeed - 10 Nov 2006
Janssen, L.P. Selects INVEGA(TM) (paliperidone) Extended Release tablets as Brand Name for Its Investigational Atypical Antipsychotic
Biopharmaceuticals
 HSMN NewsFeed - 9 Nov 2006
Barr Receives Tentative Approval for a Generic Version of ZYPREXA(R) Zydis(R) Tablets, 5mg, 10mg, 15mg and 20mg
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 8 Nov 2006
Medtronic Announces Initiation of U.S. Feasibility Trial to Evaluate Surgical Ablation Techniques to Treat Lone Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 2 Nov 2006
Synergetics Discloses Revenue Information Relating to Iridex Infringement Suit
Devices Litigation
 HSMN NewsFeed - 31 Oct 2006
New Guidelines to Treat Behavior Problems Following Traumatic Brain Injury Published in Journal of Neurotrauma
Biopharmaceuticals Neurology Neurosurgery
 HSMN NewsFeed - 26 Oct 2006
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
Biopharmaceuticals
 HSMN NewsFeed - 26 Oct 2006
Synergetics Announces New Developments in Iridex Litigation
Devices Surgery Litigation
 HSMN NewsFeed - 20 Oct 2006
FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Oct 2006
U.S. District Court Upholds RISPERDAL(R) Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Oct 2006
Laparoscopic Surgery Pioneer Invents New Device; Patton Surgical to Develop the Hasson H2(TM)
Devices Surgery
 HSMN NewsFeed - 12 Oct 2006
Teva Announces Tentative Approval for Generic Risperdal(R) Oral Solution
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Oct 2006
Synergetics USA Announces First Malis(R) Advantage(TM) Shipments
Devices Neurosurgery
 HSMN NewsFeed - 6 Oct 2006
FDA Approves RISPERDAL(R) for Treatment of Irritability Associated with Autistic Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Sep 2006
FDA Issues Approvable Letter for Paliperidone ER for the Treatment of Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Sep 2006
Government Approves Lilly's Medicare Part D Patient Assistance Program
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Sep 2006
FDA Approves New Epilepsy Indication For Lamictal(R)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Sep 2006
Cyberonics Provides TRD Post Approval Patient Access and Outcomes Update
Devices Neurology
 HSMN NewsFeed - 10 Sep 2006
AtriCure Receives CE Mark Approval for Cardiac Arrhythmia Treatment With Isolator(TM) Transpolar(TM) Clamps in Europe
Devices Cardiology Regulatory
 HSMN NewsFeed - 17 Aug 2006
Bristol-Myers Squibb and Otsuka Pharmaceutical Company Launch New Rapidly Disintegrating Oral Antipsychotic Medication ABILIFY(R) DISCMELT(TM) (aripiprazole)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 1 Aug 2006
New Data Demonstrate Effectiveness of LAMICTAL(R) (lamotrigine) as Adjunctive Therapy for Children and Adolescents With Primary Generalized Tonic-Clonic (PGTC) Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Jul 2006
AtriCure Announces Resignation of Chief Financial Officer - Thomas J. Etergino
Devices Personnel
 HSMN NewsFeed - 20 Jul 2006
AtriCure Receives FDA 510(k) Clearance for Multifunctional Isolator(TM) Transpolar (TM) Pen System and Releases New Isolator Transpolar Open Clamp
Devices Cardiology FDA
 HSMN NewsFeed - 18 Jul 2006
KARL STORZ Prepares for Launch of the New Bipolar Resectoscope and AUTOCON(R) II 400 ESU
Devices Surgery
 HSMN NewsFeed - 18 Jul 2006
AstraZeneca Submits NDA for Sustained Release Formulation of SEROQUEL(R) for Schizophrenia Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Jul 2006
Synergetics Responds to Iridex Press Release on the Markman Ruling in Its Pending Patent Case Against Synergetics
Devices Litigation
 HSMN NewsFeed - 6 Jul 2006
Vanda Pharmaceuticals Names Dr. Paolo Baroldi Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 6 Jul 2006
Philips and Dartmouth Announce Research Collaboration to Advance Discovery in Cancer, Heart, and Neurological Diseases
Devices Radiology
 HSMN NewsFeed - 29 Jun 2006
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals
 HSMN NewsFeed - 29 Jun 2006
Shire's DAYTRANA(TM), First Transdermal Medication for Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children, Now Available in Pharmacies
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 1 Jun 2006
Alpharma Names Dean J. Mitchell President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2006
ESTECH Launches AFfirm(TM), First Cardiac Surgery Product Indicated for Use in the Treatment of Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 25 May 2006
Desvenlafaxine Succinate (DVS-233) Phase 3 Data Show Significant Improvement in Symptoms of Depression in Adult Patients Versus Placebo
Biopharmaceuticals
 HSMN NewsFeed - 25 May 2006
Six-Month Study Evaluated Effectiveness of Aripiprazole and Standard of Care In Management of Community-Treated Patients with Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 24 May 2006
Kirwan Surgical Bolsters Aura Product Line with Introduction of Progressive 70-Watt Irrigating Bipolar Electrosurgical Coagulator
Devices Surgery
 HSMN NewsFeed - 23 May 2006
New Study Reports Venlafaxine Extended Release May Help Adult Patients Prevent New Episodes of Depression for Up to Two Years
Biopharmaceuticals
 HSMN NewsFeed - 23 May 2006
Second Investigational Study of SEROQUEL(R) in the Treatment of Depressive Episodes Associated with Bipolar Disorder Confirms Previous Findings
Biopharmaceuticals
 HSMN NewsFeed - 23 May 2006
Clinical Study of Investigational Drug Paliperidone ER Demonstrated Efficacy and Tolerability in the Treatment of Patients With Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2006
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2006
First Head-to-Head Study Suggests Significantly Greater Symptom Improvement for Symbyax(R) Compared to Lamotrigine in Bipolar Depression
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2006
SureTek Medical Receives Four Clearances from FDA Office of Device Evaluation
Devices Surgery FDA
 HSMN NewsFeed - 22 May 2006
Two Studies Indicate Coblation(R) Safely Treats Symptomatic Chondral Defects in the Knee
Devices Orthopaedic
 HSMN NewsFeed - 16 May 2006
ABILIFY(R) (Aripiprazole) Demonstrated Efficacy as Maintenance Therapy In Adults with Bipolar I Disorder Following Treatment for a Recent Manic or Mixed Episode
Biopharmaceuticals
 HSMN NewsFeed - 16 May 2006
Synergetics Receives CE Mark Approval on Malis(R) Line of Products
Devices Regulatory
 HSMN NewsFeed - 9 May 2006
Synergetics Introduces Own Line of Malis(R) Bipolar Forceps
Devices Surgery
 HSMN NewsFeed - 4 May 2006
Lumenis Announces Sales Agreement for New Aluma(TM) Skin Renewal Systems with Fasel of Italy
Devices Dermatology Distribution
 HSMN NewsFeed - 2 May 2006
St. Jude Medical Announces Regulatory Approvals and Market Launch of the QuickSite XL Lead
Devices Cardiology FDA
 HSMN NewsFeed - 27 Apr 2006
Study Results Show Coblation(R) Technology Preserves Same Amount of Healthy Cells as Mechanical Shaver in Treatment of Meniscus
Devices Orthopaedic
 HSMN NewsFeed - 26 Apr 2006
Synergetics USA, Inc. Adds IRIDEX to Existing Patent Infringement Lawsuit
Devices Litigation
 HSMN NewsFeed - 10 Apr 2006
St. Jude Medical Announces Regulatory Approvals and Market Launch of the World's Thinnest ICD Lead
Devices Cardiology FDA
 HSMN NewsFeed - 27 Mar 2006
TissueLink Medical Announces Presentation of New Clinical Data Documenting Reduction in Blood Loss with the Company's Bipolar Sealing Technology
Devices Surgery
 HSMN NewsFeed - 24 Mar 2006
New Dosages of RISPERDAL(R) (Risperidone) Now Available
Biopharmaceuticals
 HSMN NewsFeed - 1 Mar 2006
Synergetics USA, Inc. Taps the Spinal and ENT Markets
Devices Surgery
 HSMN NewsFeed - 28 Feb 2006
U.S. Food and Drug Administration Approves EMSAM(R) (selegiline transdermal system), the First Transdermal Patch for the Treatment of Major Depressive Disorder
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 7 Feb 2006
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. Announce Availability of 2 mg ABILIFY(R) (aripiprazole) Tablet and Nonrefrigerated Oral Solution
Biopharmaceuticals
 HSMN NewsFeed - 18 Jan 2006
Cyberonics Announces Closure of Investigational Device Exemption (IDE) for Treatment-Resistant Depression (TRD), Lifetime Reimbursement Guarantee for All TRD IDE Study Patients and $15 Million TRD Indigent Care Program
Devices Neurology Reimbursement
 HSMN NewsFeed - 12 Jan 2006
Teva Announces Tentative Approval of Divalproex Sodium Delayed-Release Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Jan 2006
Silverglide Surgical Wins Legal Dispute Over Proprietary Technology
Devices Litigation
 HSMN NewsFeed - 9 Jan 2006
Synergetics USA, Inc. Announces New Three Year Agreements with Codman & Shurtleff, Inc.
Devices Distribution
 HSMN NewsFeed - 3 Jan 2006
AstraZeneca Submits sNDA for SEROQUEL(R) for Bipolar Depression Treatment
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 185

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 185 additional stories matching:
bipolar
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.